JUNS:Jupiter Neurosciences Inc - Stock Price Quote and Dividend Data
JUNS STOCK PRICE LATEST CLOSE
$0.58
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
Jupiter Neurosciences Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
Jupiter Neurosciences Inc Stock Price Information
52-Week Low/High Stock Price$0.53 - $19.51
Percent Held by Institutions0.00%
Revenue$0
Net Income$-3,762,797
Cash Flow$-7,595,293
EPS-0.05%
Market Cap$19,041,421
PE Ratio to Industry40%
Debt-Equity Ratio3.51%
Debt-Equity to Industry1.42%
Total Return Last 12 Months0.00%
Total Return Last 3 Years0.00%
Total Return Last 5 Years0.00%
Latest Trade DateApr. 08, 2025
Jupiter Neurosciences Inc Annual Stock Dividends
No Data available for Payment History.
Jupiter Neurosciences Inc Dividend Payment History
| No dividends retrieved for JUNS |
Jupiter Neurosciences Inc Other Dividend Details
Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. Co. has developed a resveratrol platform product targeting treatment of neuro-inflammation. The product, called JOTROL™, has various potential indications of use for diseases, which of Co. is primarily targeting Mucopolysaccharidoses Type 1, Friedreich's Ataxia, and Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes syndrome and with Amyotrophic Lateral Sclerosis in an early development stage. In the larger disease areas, Co. is primarily targeting Mild Cognitive Impairment/early Alzheimer's disease with Traumatic Brain Injury /concussions and Covid-19 in early development stages.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Apr. 01, 2025JUNS STOCK PRICE DECREASE: Jupiter Neurosciences Inc on 04-01-2025 decreased stock price > 10% from $0.70 to $0.61
Mar. 04, 2025JUNS STOCK PRICE DECREASE: Jupiter Neurosciences Inc on 03-04-2025 decreased stock price > 10% from $0.65 to $0.58
Feb. 26, 2025JUNS STOCK PRICE DECREASE: Jupiter Neurosciences Inc on 02-26-2025 decreased stock price > 10% from $0.77 to $0.69
Feb. 08, 2025JUNS STOCK PRICE DECREASE: Jupiter Neurosciences Inc on 02-08-2025 decreased stock price > 10% from $1.02 to $0.87
Feb. 05, 2025JUNS STOCK PRICE INCREASE: Jupiter Neurosciences Inc on 02-05-2025 increased stock price > 10% from $0.97 to $1.08
Jan. 29, 2025JUNS STOCK PRICE INCREASE: Jupiter Neurosciences Inc on 01-29-2025 increased stock price > 10% from $1.20 to $1.32
Jan. 28, 2025JUNS STOCK PRICE DECREASE: Jupiter Neurosciences Inc on 01-28-2025 decreased stock price > 10% from $1.41 to $1.20
Jan. 24, 2025JUNS STOCK PRICE DECREASE: Jupiter Neurosciences Inc on 01-24-2025 decreased stock price > 10% from $3.58 to $1.45
Jan. 23, 2025JUNS STOCK PRICE DECREASE: Jupiter Neurosciences Inc on 01-23-2025 decreased stock price > 10% from $5.42 to $3.58
Jan. 22, 2025JUNS STOCK PRICE INCREASE: Jupiter Neurosciences Inc on 01-22-2025 increased stock price > 10% from $4.40 to $5.42
Apr. 09, 2025MTSR STOCK PRICE DECREASE: Metsera Inc on 04-09-2025 decreased stock price > 10% from $16.45 to $14.21
Apr. 09, 2025RNTX STOCK PRICE DECREASE: Rein Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $1.64 to $1.39
Apr. 09, 2025IRD STOCK PRICE DECREASE: Opus Genetics Inc on 04-09-2025 decreased stock price > 10% from $0.85 to $0.75
Apr. 09, 2025DWTX STOCK PRICE DECREASE: Dogwood Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $4.05 to $3.61
Apr. 09, 2025CLYM STOCK PRICE DECREASE: Climb Bio Inc on 04-09-2025 decreased stock price > 10% from $1.26 to $1.13
Apr. 09, 2025KAPA STOCK PRICE DECREASE: Kairos Pharma Ltd on 04-09-2025 decreased stock price > 10% from $1.14 to $0.97
Apr. 09, 2025IBO STOCK PRICE DECREASE: Impact Biomedical Inc on 04-09-2025 decreased stock price > 10% from $0.87 to $0.65
Apr. 09, 2025ZBIO STOCK PRICE DECREASE: Zenas BioPharma Inc on 04-09-2025 decreased stock price > 10% from $7.75 to $6.77
Apr. 09, 2025EVOK STOCK PRICE DECREASE: Com Par $0.0001/Evoke Pharma Inc on 04-09-2025 decreased stock price > 10% from $2.35 to $2.07
Apr. 09, 2025TNFA STOCK PRICE DECREASE: TNF Pharmaceuticals Inc on 04-09-2025 decreased stock price > 10% from $0.37 to $0.26
